Literature DB >> 31567127

Heparin-Induced Thrombocytopenia and Cardiac Surgery: Can We Do It All With Cangrelor?

Kenichi A Tanaka1, Reney Henderson, Brittney Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31567127      PMCID： PMC6818991          DOI： 10.1213/XAA.0000000000001094

Source DB:  PubMed          Journal:  A A Pract        ISSN： 2575-3126


× No keyword cloud information.
  4 in total

1.  Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness.

Authors:  N Kakouros; T S Kickler; K M Laws; J J Rade
Journal:  J Thromb Haemost       Date:  2013-10       Impact factor: 5.824

Review 2.  How I use laboratory monitoring of antiplatelet therapy.

Authors:  Alan D Michelson; Deepak L Bhatt
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

3.  Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.

Authors:  A Koster; M Kukucka; F Bach; O Meyer; T Fischer; F Mertzlufft; M Loebe; R Hetzer; H Kuppe
Journal:  Anesthesiology       Date:  2001-02       Impact factor: 7.892

4.  Successful Use of Cangrelor and Heparin for Cardiopulmonary Bypass in a Patient With Heparin-Induced Thrombocytopenia and End-Stage Renal Disease: A Case Report.

Authors:  Alexander M Girgis; Eugene Golts; Doug Humber; Dalia A Banks
Journal:  A A Pract       Date:  2019-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.